Skip to main content
SpringerLink
Log in

Clinical trials report

  • Published:
Current Diabetes Reports Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Drucker DJ: Development of glucagon-like peptide-1-based pharmaceuticals as therapeutic agents for the treatment of diabetes. Curr Pharm Des 2001, 7:1399–1412.

    Article  PubMed  CAS  Google Scholar 

  2. Lam NT, Kieffer TJ: The multifaceted potential of glucagons-like peptide-1 as a therapeutic agent. Minerva Endocrinol 2002, 27:79–93.

    PubMed  CAS  Google Scholar 

  3. Egan JM, Clocquet AR, Elahi D: The insulinotropic effect of acute exendin-4 administered to humans: comparison of nondiabetic state to type 2 diabetes. J Clin Endocrinol Metab 2002, 87:1282–1290.

    Article  PubMed  CAS  Google Scholar 

  4. Agerso H, Jensen LB, Elbrond B, et al.: The pharmacokinetics, pharmacodynamics, safety and tolerability of NN2211, a new long-acting GLP-1 derivative, in healthy men. Diabetologia 2002, 45:195–202.

    Article  PubMed  CAS  Google Scholar 

  5. Ahren B, Simonsson E, Larsson H, et al.: Inhibition of dipeptidyl peptidase IV improves metabolic control over a 4-week study period in type 2 diabetes. Diabetes Care 2002, 25:869–875.

    Article  PubMed  CAS  Google Scholar 

  6. Tuomilehto J, Lindstrom J, Eriksson JG, et al.: Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001, 344:1343–1350.

    Article  PubMed  CAS  Google Scholar 

  7. Khaw K-T, Wareham N, Luben R, et al.: Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of European Prospective Investigation of Cancer and Nutrition (EPIC-Norfolk). BMJ 2001, 322:1–6.

    Article  Google Scholar 

  8. Stratton IM, Adler AI, Neil HA, et al.: Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000, 321:405–412.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. Anthony L. McCall MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

McCall, A.L. Clinical trials report. Curr Diab Rep 2, 393–395 (2002). https://doi.org/10.1007/s11892-002-0102-6

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11892-002-0102-6

Keywords

Search

Navigation